Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27975 | 16821419 | Ter Arkh | [Fatty hepatosis. Non-alcoholic steatohepatitis (evolution of the knowledge about clinico-morphological features, prognosis, treatment)]. | 2006 | Details |
| A27976 | 16819398 | J Pediatr Gastroenterol Nutr | Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study. | 2006 | Details |
| A27977 | 16817817 | Clin Endocrinol (Oxf) | Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. | 2006 | Details |
| A27978 | 16809950 | Korean J Gastroenterol | [Association of hepatic iron deposition and serum iron indices with hepatic inflammation and fibrosis stage in nonalcoholic fatty liver disease]. | 2006 | Details |
| A27979 | 16807517 | Ann Hepatol | Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). | 2006 | Details |
| A27980 | 16804347 | Korean J Hepatol | [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease]. | 2006 | Details |
| A27981 | 16801180 | Acta Paediatr | Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging. | 2006 | Details |
| A27982 | 16799979 | Hepatology | In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. | 2006 | Details |
| A27983 | 16797327 | Transplant Proc | The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation. | 2006 | Details |
| A27984 | 16796890 | Zhonghua Yi Xue Za Zhi | [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats]. | 2006 | Details |
| A27985 | 16793619 | Nan Fang Yi Ke Da Xue Xue Bao | [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease]. | 2006 | Details |
| A27986 | 16792872 | Zhonghua Gan Zang Bing Za Zhi | [Evaluation of leptin receptor Lys109Arg polymorphism in patients with non-alcoholic fatty liver disease]. | 2006 | Details |
| A27987 | 16792871 | Zhonghua Gan Zang Bing Za Zhi | [A clinical and pathological study of nonalcoholic fatty liver disease]. | 2006 | Details |
| A27988 | 16787375 | Mini Rev Med Chem | Adiponectin, structure, function and pathophysiological implications in non-alcoholic fatty liver disease. | 2006 | Details |
| A27989 | 16783524 | Dig Dis Sci | Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image. | 2006 | Details |
| A27990 | 16778754 | Minerva Cardioangiol | Nonalcoholic fatty liver disease and the metabolic syndrome. | 2006 | Details |
| A27991 | 16773685 | World J Gastroenterol | Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. | 2006 | Details |
| A27992 | 16768128 | Nihon Rinsho | [Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC)]. | 2006 | Details |
| A27993 | 16768124 | Nihon Rinsho | [Clinical utility of angiotensin II receptor antagonist]. | 2006 | Details |
| A27994 | 16768122 | Nihon Rinsho | [Treatment of NASH: nutritional counseling and physical exercise]. | 2006 | Details |
| A27995 | 16768121 | Nihon Rinsho | [High-sensitivity C-reactive protein (hs-CRP): a promising biomarker for the screening of non-alcoholic steatohepatitis (NASH)]. | 2006 | Details |
| A27996 | 16768120 | Nihon Rinsho | [Imaging of NASH]. | 2006 | Details |
| A27997 | 16768119 | Nihon Rinsho | [Role of liver biopsy in the diagnosis of NASH]. | 2006 | Details |
| A27998 | 16768118 | Nihon Rinsho | [Clinical features of NASH]. | 2006 | Details |
| A27999 | 16768110 | Nihon Rinsho | [NASH model-- role of interleukin-1 receptor]. | 2006 | Details |
| A28000 | 16768107 | Nihon Rinsho | [Rabbit model for the study of human NASH]. | 2006 | Details |
| A28001 | 16768105 | Nihon Rinsho | [Diagnostic criteria for non-alcoholic steatohepatitis]. | 2006 | Details |
| A28002 | 16768104 | Nihon Rinsho | [Nonalcoholic steatohepatitis: a brief review on its concept]. | 2006 | Details |
| A28003 | 16768103 | Nihon Rinsho | [Current trends of NASH/NAFLD in Asia-Pacific region]. | 2006 | Details |
| A28004 | 16766393 | Biomarkers | Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. | 2006 | Details |
| A28005 | 16762625 | Gastroenterology | Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. | 2006 | Details |
| A28006 | 16762007 | Liver Int | Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. | 2006 | Details |
| A28008 | 16751709 | J Endocrinol Invest | Endocannabinoids as novel mediators of liver diseases. | 2006 | Details |
| A28009 | 16750661 | Dig Liver Dis | Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. | 2006 | Details |
| A28010 | 28316519 | Gastroenterol Hepatol (N Y) | Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment. | 2006 | Details |
| A28011 | 16733858 | World J Gastroenterol | Non-alcoholic fatty liver disease may not be a severe disease at presentation among Asian Indians. | 2006 | Details |
| A28012 | 16732016 | Diabetes Care | Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. | 2006 | Details |
| A28014 | 16723850 | Am J Surg Pathol | Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis. | 2006 | Details |
| A28015 | 16712671 | Clin Endocrinol (Oxf) | Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. | 2006 | Details |
| A28016 | 16709309 | Curr Med Res Opin | Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. | 2006 | Details |
| A28017 | 16706829 | J Gastroenterol Hepatol | Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary? | 2006 | Details |
| A28018 | 16706825 | J Gastroenterol Hepatol | Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. | 2006 | Details |
| A28019 | 16706822 | J Gastroenterol Hepatol | Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis. | 2006 | Details |
| A28023 | 16697719 | Gastroenterology | Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. | 2006 | Details |
| A28024 | 16696815 | Aliment Pharmacol Ther | A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. | 2006 | Details |
| A28025 | 16696395 | J Med Assoc Thai | Serum leptin concentrations in chronic hepatitis. | 2006 | Details |
| A28026 | 16691301 | Can J Gastroenterol | Non alcoholic fatty liver disease: a clinical approach and review. | 2006 | Details |
| A28027 | 16689200 | J Chin Med Assoc | Nonalcoholic fatty liver disease manifesting esophageal variceal bleeding. | 2006 | Details |
| A28028 | 16684857 | Am J Physiol Endocrinol Metab | Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. | 2006 | Details |
| A28029 | 16682043 | Atherosclerosis | Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. | 2006 | Details |
| A28030 | 16680031 | Curr Opin Lipidol | New insights in the pathogenesis of non-alcoholic fatty liver disease. | 2006 | Details |
| A28031 | 16679470 | Postgrad Med J | Treatment of non-alcoholic fatty liver disease. | 2006 | Details |
| A28032 | 16673555 | Acta Gastroenterol Belg | Serum vitamin-E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. | 2006 | Details |
| A28033 | 16649140 | Cell Mol Life Sci | Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. | 2006 | Details |
| A28034 | 16638699 | Scand J Gastroenterol | Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study. | 2006 | Details |
| A28035 | 16637558 | Pediatr Ann | Nonalcoholic fatty liver disease. | 2006 | Details |
| A28036 | 16633331 | Panminerva Med | The metabolic syndrome and nonalcoholic fatty liver disease. | 2006 | Details |
| A28037 | 16630771 | Clin Gastroenterol Hepatol | A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. | 2006 | Details |
| A28038 | 16628637 | Hepatology | Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. | 2006 | Details |
| A28039 | 16624332 | Life Sci | High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. | 2006 | Details |
| A28040 | 16620269 | Diabet Med | Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A28041 | 16618517 | J Hepatol | Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. | 2006 | Details |
| A28043 | 16611275 | Aliment Pharmacol Ther | Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. | 2006 | Details |
| A28044 | 16610015 | World J Gastroenterol | Treatment of nonalcoholic fatty liver disease. | 2006 | Details |
| A28045 | 16609997 | World J Gastroenterol | Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. | 2006 | Details |
| A28046 | 16603729 | Am J Physiol Gastrointest Liver Physiol | Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. | 2006 | Details |
| A28047 | 16603025 | Clin Sci (Lond) | Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. | 2006 | Details |
| A28049 | 16595594 | J Clin Endocrinol Metab | Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. | 2006 | Details |
| A28050 | 16573713 | Fundam Clin Pharmacol | Effect of hyperleptinaemia on chronic ethanol-induced hepatotoxicity in mice. | 2006 | Details |
| A28051 | 28286458 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. | 2006 | Details |
| A28052 | 19858588 | Saudi J Gastroenterol | The role of leptin in non-alcoholic fatty liver disease. | 2009 | Details |
| A28053 | 16565603 | Korean J Hepatol | [Insulin resistance in non-alcoholic fatty liver disease]. | 2006 | Details |
| A28054 | 16564703 | Cytokine | Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A28055 | 16557185 | Minerva Gastroenterol Dietol | Non-alcoholic fatty liver disease and hepatitis C infection. | 2006 | Details |
| A28056 | 16553034 | J Endocrinol Invest | Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. | 2006 | Details |
| A28057 | 16545157 | Obes Surg | Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. | 2006 | Details |
| A28059 | 16540770 | J Clin Gastroenterol | Therapy of NAFLD: insulin sensitizing agents. | 2006 | Details |
| A28060 | 16540769 | J Clin Gastroenterol | Therapy of NAFLD: antioxidants and cytoprotective agents. | 2006 | Details |
| A28061 | 16540768 | J Clin Gastroenterol | The epidemiology of nonalcoholic fatty liver disease in adults. | 2006 | Details |
| A28062 | 16540766 | J Clin Gastroenterol | Weight loss as a treatment for nonalcoholic fatty liver disease. | 2006 | Details |
| A28063 | 16540765 | J Clin Gastroenterol | Diagnostic evaluation of nonalcoholic fatty liver disease. | 2006 | Details |
| A28064 | 16540764 | J Clin Gastroenterol | Genetic influences in nonalcoholic fatty liver disease. | 2006 | Details |
| A28065 | 16540762 | J Clin Gastroenterol | Pathophysiology of nonalcoholic steatohepatitis. | 2006 | Details |
| A28066 | 16540761 | J Clin Gastroenterol | Natural history of nonalcoholic steatohepatitis. | 2006 | Details |
| A28067 | 16534679 | Dig Dis Sci | Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? | 2006 | Details |
| A28068 | 16531961 | Ann Hepatol | Pentoxifylline does not prevent neither liver damage nor early profibrogenic events in a rat model of non-alcoholic steatohepatitis. | 2006 | Details |
| A28069 | 16531927 | Nucl Med Commun | Colloid scintigraphy in non-alcoholic steatohepatitis: a conventional diagnostic method for an emerging disease. | 2006 | Details |
| A28071 | 16521351 | Clin Med (Lond) | Non-alcoholic fatty liver disease: current concepts and management strategies. | 2007 | Details |
| A28072 | 16516152 | Biochem Biophys Res Commun | Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice. | 2006 | Details |
| A28073 | 16514570 | Z Gastroenterol | Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure. | 2006 | Details |
| A28074 | 16506276 | Diabetes Metab Res Rev | Diabetes in chronic liver disease: from old concepts to new evidence. | 2006 | Details |
| A28075 | 16505490 | J Biol Chem | Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. | 2006 | Details |
| A28076 | 16503961 | BMC Gastroenterol | Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A28077 | 16503761 | Expert Opin Investig Drugs | Recent findings concerning thiazolidinediones in the treatment of diabetes. | 2006 | Details |
| A28079 | 16672828 | J Clin Gastroenterol | Therapy of NAFLD: Insulin Sensitizing Agents. | 2006 | Details |
| A28080 | 16672820 | J Clin Gastroenterol | Pathophysiology of Nonalcoholic Steatohepatitis. | 2006 | Details |
| A28081 | 16496750 | Recenti Prog Med | [Steatosis and hepatitis C]. | 2005 | Details |
| A28082 | 16496325 | Hepatology | Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. | 2006 | Details |
| A28083 | 16491048 | Minerva Gastroenterol Dietol | The pathology of nonalcoholic steatohepatitis. | 2002 | Details |
| A28084 | 16489632 | World J Gastroenterol | Non-alcoholic fatty liver disease and the metabolic syndrome: effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? | 2006 | Details |